SHTDY SINOPHARM GROUP COWatchlist
About SINOPHARM GROUP CO Company
Sinopharm Group Co., Ltd. is a distributor of pharmaceutical and healthcare products and a value added supply chain service provider in the People's Republic of China. It operates through the following business segments: Pharmaceutical Distribution, Medical Devices, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment provides distribution, logistics and other value-added services for domestic and international pharmaceutical and healthcare products manufacturers and other suppliers. The Medical Devices segment consists of the distribution of medical devices in China. The Retail Pharmacy segment refers to the network of retail drug stores in major cities of China via direct operations and franchises. The Other Business segment comprises of the production and sale of pharmaceutical products, chemical reagents and laboratory supplies. The company was founded on January 8, 2003 and is headquartered in Shanghai, China.
Sinopharm Group (HKG:1099) Seems To Use Debt Quite Sensibly
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of permanent loss is the risk I worry about... and every practical investor I know wor
Sinopharm Holdings (01099.HK) was reduced by 1,754 million shares by FMR LLC
Gelonghui November 16 | According to the latest equity disclosure data from the Stock Exchange, on November 10, 2023, Sinopharm Holdings (01099.HK) was reduced by 1,754 million shares by FMR LLC at an average price of HK$19.1627 per share, involving approximately HK$32.681 million. After reducing its holdings, the latest number of shares held by FMR LLC was 160,276,364 shares, and the shareholding ratio fell from 12.07% to 11.94%.
An Intrinsic Calculation For Sinopharm Group Co. Ltd. (HKG:1099) Suggests It's 26% Undervalued
Key Insights The projected fair value for Sinopharm Group is HK$26.57 based on 2 Stage Free Cash Flow to Equity Current share price of HK$19.60 suggests Sinopharm Group is potentially 26% undervalue
Sinopharm is principally engaged in pharmaceutical and medical devices distribution business. The Company operates its business through four segments. Pharmaceutical Distribution segment is engaged in the distribution of pharmaceutical products to hospitals, other distributors, retail pharmacy stores and clinics. Medical Devices segment is engaged in the distribution of medical devices, as well as provides installation and maintenance services. Retail Pharmacy segment is en...